Alere delivers reliable and actionable health information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Our high-performance diagnostics for infectious disease, cardiometabolic disease and toxicology are designed to meet the growing global demand for accurate,easy-to-use and cost-effective near-patient tests. Our goal is to make Alere products accessible to more people around the world, even those located in remote and resource-limited areas, by making them affordable and usable in any setting. By making critical clinical diagnostic information available to doctors and patients in an actionable timeframe, Alere products help streamline healthcare delivery and improve patient outcomes. Our company is a Delaware corporation formed in 2001. Our common stock, par value $0.001 per share, is listed on the New York Stock Exchange under the symbol “ALR.” Our Series B Convertible Perpetual Preferred Stock, par value $0.001 per share, or Series B Preferred Stock, is listed on the New York Stock Exchange under the symbol“ALR-B.”
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Inverness Medical Innovations Inc
SEC CIK
Corporate docs
IRS number
43565120
Latest filings (excl ownership)
15-12B
Securities registration termination
8 Nov 17
15-12B
Securities registration termination
8 Nov 17
EFFECT
Notice of effectiveness
7 Nov 17
EFFECT
Notice of effectiveness
7 Nov 17
EFFECT
Notice of effectiveness
7 Nov 17
EFFECT
Notice of effectiveness
7 Nov 17
EFFECT
Notice of effectiveness
7 Nov 17
EFFECT
Notice of effectiveness
7 Nov 17
EFFECT
Notice of effectiveness
7 Nov 17
EFFECT
Notice of effectiveness
7 Nov 17
Latest ownership filings
Institutional ownership, Q2 2022
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|